 | • レポートコード：C-GIR20G3078 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「腫瘍特異抗原の世界市場2019年」は、グローバルにおける腫瘍特異抗原市場を展望するレポートです。腫瘍特異抗原のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・腫瘍特異抗原の市場概観 ・腫瘍特異抗原の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腫瘍特異抗原の企業別販売動向、市場シェア、市場集中度、競争動向 ・腫瘍特異抗原の世界市場規模 ・腫瘍特異抗原の北米市場分析（アメリカ、カナダ、メキシコ等） ・腫瘍特異抗原のアメリカ市場規模推移 ・腫瘍特異抗原のカナダ市場規模推移 ・腫瘍特異抗原のメキシコ市場規模推移 ・腫瘍特異抗原のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・腫瘍特異抗原のドイツ市場規模推移 ・腫瘍特異抗原のイギリス市場規模推移 ・腫瘍特異抗原のロシア市場規模推移 ・腫瘍特異抗原のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・腫瘍特異抗原の日本市場規模推移 ・腫瘍特異抗原の中国市場規模推移 ・腫瘍特異抗原の韓国市場規模推移 ・腫瘍特異抗原のインド市場規模推移 ・腫瘍特異抗原の東南アジア市場規模推移 ・腫瘍特異抗原の南米市場分析（ブラジル、アルゼンチン等） ・腫瘍特異抗原の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・腫瘍特異抗原の種類別分析/販売量、売上、市場シェア（コーディング領域、非コーディング領域） ・腫瘍特異抗原の用途別分析/市場規模（創薬＆開発、診断、臨床および基礎研究、その他） ・腫瘍特異抗原の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・腫瘍特異抗原の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Tumor-Specific Antigen market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tumor-Specific Antigen.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Tumor-Specific Antigen market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tumor-Specific Antigen market by product type and applications/end industries.
Market Segment by Companies, this report covers
Agilent Technologies
Roche
Lee Biosolutions
Creative Diagnostics
Caris Life Sciences
Go Therapeutics
Merck Group
Biomrieux
Bio-Rad
Abcam
PerkinElmer
OriGene Technologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Coding Region
Non-Coding Region
Market Segment by Applications, can be divided into
Drug Discovery and Development
Diagnostics
Clinical and Basic Research
Others
Table of Contents
1 Tumor-Specific Antigen Market Overview
1.1 Product Overview and Scope of Tumor-Specific Antigen
1.2 Classification of Tumor-Specific Antigen by Types
1.2.1 Global Tumor-Specific Antigen Revenue Comparison by Types (2019-2024)
1.2.2 Global Tumor-Specific Antigen Revenue Market Share by Types in 2018
1.2.3 Coding Region
1.2.4 Non-Coding Region
1.3 Global Tumor-Specific Antigen Market by Application
1.3.1 Global Tumor-Specific Antigen Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Drug Discovery and Development
1.3.3 Diagnostics
1.3.4 Clinical and Basic Research
1.3.5 Others
1.4 Global Tumor-Specific Antigen Market by Regions
1.4.1 Global Tumor-Specific Antigen Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Tumor-Specific Antigen Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tumor-Specific Antigen Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tumor-Specific Antigen Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Tumor-Specific Antigen Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tumor-Specific Antigen Status and Prospect (2014-2024)
1.5 Global Market Size of Tumor-Specific Antigen (2014-2024)
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Business Overview
2.1.2 Tumor-Specific Antigen Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Agilent Technologies Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche
2.2.1 Business Overview
2.2.2 Tumor-Specific Antigen Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.3 Lee Biosolutions
2.3.1 Business Overview
2.3.2 Tumor-Specific Antigen Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Lee Biosolutions Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.4 Creative Diagnostics
2.4.1 Business Overview
2.4.2 Tumor-Specific Antigen Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Creative Diagnostics Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.5 Caris Life Sciences
2.5.1 Business Overview
2.5.2 Tumor-Specific Antigen Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Caris Life Sciences Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.6 Go Therapeutics
2.6.1 Business Overview
2.6.2 Tumor-Specific Antigen Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Go Therapeutics Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck Group
2.7.1 Business Overview
2.7.2 Tumor-Specific Antigen Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Group Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.8 Biomrieux
2.8.1 Business Overview
2.8.2 Tumor-Specific Antigen Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biomrieux Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bio-Rad
2.9.1 Business Overview
2.9.2 Tumor-Specific Antigen Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bio-Rad Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.10 Abcam
2.10.1 Business Overview
2.10.2 Tumor-Specific Antigen Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Abcam Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.11 PerkinElmer
2.11.1 Business Overview
2.11.2 Tumor-Specific Antigen Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 PerkinElmer Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
2.12 OriGene Technologies
2.12.1 Business Overview
2.12.2 Tumor-Specific Antigen Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 OriGene Technologies Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
3 Global Tumor-Specific Antigen Market Competition, by Players
3.1 Global Tumor-Specific Antigen Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Tumor-Specific Antigen Players Market Share
3.2.2 Top 10 Tumor-Specific Antigen Players Market Share
3.3 Market Competition Trend
4 Global Tumor-Specific Antigen Market Size by Regions
4.1 Global Tumor-Specific Antigen Revenue and Market Share by Regions
4.2 North America Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
4.3 Europe Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
4.5 South America Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
5 North America Tumor-Specific Antigen Revenue by Countries
5.1 North America Tumor-Specific Antigen Revenue by Countries (2014-2019)
5.2 USA Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
5.3 Canada Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
5.4 Mexico Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
6 Europe Tumor-Specific Antigen Revenue by Countries
6.1 Europe Tumor-Specific Antigen Revenue by Countries (2014-2019)
6.2 Germany Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
6.3 UK Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
6.4 France Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
6.5 Russia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
6.6 Italy Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Tumor-Specific Antigen Revenue by Countries
7.1 Asia-Pacific Tumor-Specific Antigen Revenue by Countries (2014-2019)
7.2 China Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
7.3 Japan Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
7.4 Korea Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
7.5 India Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
8 South America Tumor-Specific Antigen Revenue by Countries
8.1 South America Tumor-Specific Antigen Revenue by Countries (2014-2019)
8.2 Brazil Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
8.3 Argentina Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
8.4 Colombia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Tumor-Specific Antigen by Countries
9.1 Middle East and Africa Tumor-Specific Antigen Revenue by Countries (2014-2019)
9.2 Saudi Arabia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
9.3 UAE Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
9.4 Egypt Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
9.5 Nigeria Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
9.6 South Africa Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
10 Global Tumor-Specific Antigen Market Segment by Type
10.1 Global Tumor-Specific Antigen Revenue and Market Share by Type (2014-2019)
10.2 Global Tumor-Specific Antigen Market Forecast by Type (2019-2024)
10.3 Coding Region Revenue Growth Rate (2014-2024)
10.4 Non-Coding Region Revenue Growth Rate (2014-2024)
11 Global Tumor-Specific Antigen Market Segment by Application
11.1 Global Tumor-Specific Antigen Revenue Market Share by Application (2014-2019)
11.2 Tumor-Specific Antigen Market Forecast by Application (2019-2024)
11.3 Drug Discovery and Development Revenue Growth (2014-2019)
11.4 Diagnostics Revenue Growth (2014-2019)
11.5 Clinical and Basic Research Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Tumor-Specific Antigen Market Size Forecast (2019-2024)
12.1 Global Tumor-Specific Antigen Market Size Forecast (2019-2024)
12.2 Global Tumor-Specific Antigen Market Forecast by Regions (2019-2024)
12.3 North America Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
12.4 Europe Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
12.6 South America Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Tumor-Specific Antigen Picture
Table Product Specifications of Tumor-Specific Antigen
Table Global Tumor-Specific Antigen and Revenue (Million USD) Market Split by Product Type
Figure Global Tumor-Specific Antigen Revenue Market Share by Types in 2018
Figure Coding Region Picture
Figure Non-Coding Region Picture
Table Global Tumor-Specific Antigen Revenue (Million USD) by Application (2014-2024)
Figure Tumor-Specific Antigen Revenue Market Share by Applications in 2018
Figure Drug Discovery and Development Picture
Figure Diagnostics Picture
Figure Clinical and Basic Research Picture
Figure Others Picture
Table Global Market Tumor-Specific Antigen Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (2014-2024)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Tumor-Specific Antigen Type and Applications
Table Agilent Technologies Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Tumor-Specific Antigen Type and Applications
Table Roche Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Lee Biosolutions Basic Information, Manufacturing Base and Competitors
Table Lee Biosolutions Tumor-Specific Antigen Type and Applications
Table Lee Biosolutions Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table Creative Diagnostics Tumor-Specific Antigen Type and Applications
Table Creative Diagnostics Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Caris Life Sciences Basic Information, Manufacturing Base and Competitors
Table Caris Life Sciences Tumor-Specific Antigen Type and Applications
Table Caris Life Sciences Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Go Therapeutics Basic Information, Manufacturing Base and Competitors
Table Go Therapeutics Tumor-Specific Antigen Type and Applications
Table Go Therapeutics Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Group Basic Information, Manufacturing Base and Competitors
Table Merck Group Tumor-Specific Antigen Type and Applications
Table Merck Group Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Biomrieux Basic Information, Manufacturing Base and Competitors
Table Biomrieux Tumor-Specific Antigen Type and Applications
Table Biomrieux Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Bio-Rad Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Tumor-Specific Antigen Type and Applications
Table Bio-Rad Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Abcam Basic Information, Manufacturing Base and Competitors
Table Abcam Tumor-Specific Antigen Type and Applications
Table Abcam Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table PerkinElmer Basic Information, Manufacturing Base and Competitors
Table PerkinElmer Tumor-Specific Antigen Type and Applications
Table PerkinElmer Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table OriGene Technologies Basic Information, Manufacturing Base and Competitors
Table OriGene Technologies Tumor-Specific Antigen Type and Applications
Table OriGene Technologies Tumor-Specific Antigen Revenue, Gross Margin and Market Share (2017-2018)
Table Global Tumor-Specific Antigen Revenue (Million USD) by Players (2014-2019)
Table Global Tumor-Specific Antigen Revenue Share by Players (2014-2019)
Figure Global Tumor-Specific Antigen Revenue Share by Players in 2017
Figure Global Tumor-Specific Antigen Revenue Share by Players in 2018
Figure Global Top 5 Players Tumor-Specific Antigen Revenue Market Share in 2018
Figure Global Top 10 Players Tumor-Specific Antigen Revenue Market Share in 2018
Figure Global Tumor-Specific Antigen Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Tumor-Specific Antigen Revenue (Million USD) by Regions (2014-2019)
Table Global Tumor-Specific Antigen Revenue Market Share by Regions (2014-2019)
Figure Global Tumor-Specific Antigen Revenue Market Share by Regions (2014-2019)
Figure Global Tumor-Specific Antigen Revenue Market Share by Regions in 2018
Figure North America Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Europe Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure South America Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Table North America Tumor-Specific Antigen Revenue by Countries (2014-2019)
Table North America Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019)
Figure North America Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019)
Figure North America Tumor-Specific Antigen Revenue Market Share by Countries in 2018
Figure USA Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Canada Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Mexico Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Table Europe Tumor-Specific Antigen Revenue (Million USD) by Countries (2014-2019)
Figure Europe Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019)
Figure Europe Tumor-Specific Antigen Revenue Market Share by Countries in 2018
Figure Germany Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure UK Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure France Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Russia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Italy Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Tumor-Specific Antigen Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Tumor-Specific Antigen Revenue Market Share by Countries in 2018
Figure China Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Japan Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Korea Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure India Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Table South America Tumor-Specific Antigen Revenue by Countries (2014-2019)
Table South America Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019)
Figure South America Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019)
Figure South America Tumor-Specific Antigen Revenue Market Share by Countries in 2018
Figure Brazil Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Argentina Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Colombia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Tumor-Specific Antigen Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Tumor-Specific Antigen Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Tumor-Specific Antigen Revenue Market Share by Countries in 2018
Figure Saudi Arabia Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure UAE Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Egypt Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure Nigeria Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Figure South Africa Tumor-Specific Antigen Revenue and Growth Rate (2014-2019)
Table Global Tumor-Specific Antigen Revenue (Million USD) by Type (2014-2019)
Table Global Tumor-Specific Antigen Revenue Share by Type (2014-2019)
Figure Global Tumor-Specific Antigen Revenue Share by Type (2014-2019)
Figure Global Tumor-Specific Antigen Revenue Share by Type in 2018
Table Global Tumor-Specific Antigen Revenue Forecast by Type (2019-2024)
Figure Global Tumor-Specific Antigen Market Share Forecast by Type (2019-2024)
Figure Global Coding Region Revenue Growth Rate (2014-2019)
Figure Global Non-Coding Region Revenue Growth Rate (2014-2019)
Table Global Tumor-Specific Antigen Revenue by Application (2014-2019)
Table Global Tumor-Specific Antigen Revenue Share by Application (2014-2019)
Figure Global Tumor-Specific Antigen Revenue Share by Application (2014-2019)
Figure Global Tumor-Specific Antigen Revenue Share by Application in 2018
Table Global Tumor-Specific Antigen Revenue Forecast by Application (2019-2024)
Figure Global Tumor-Specific Antigen Market Share Forecast by Application (2019-2024)
Figure Global Drug Discovery and Development Revenue Growth Rate (2014-2019)
Figure Global Diagnostics Revenue Growth Rate (2014-2019)
Figure Global Clinical and Basic Research Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Tumor-Specific Antigen Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Tumor-Specific Antigen Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Tumor-Specific Antigen Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
Figure Europe Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
Figure South America Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Tumor-Specific Antigen Revenue Market Forecast (2019-2024)
前立腺特異抗原（PSA）テストの世界市場 2019年版：種類別（CLIA法、ELISA法）、用途別（スクリーニング、治療後モニタリング、その他） Scope of the Report: The global Prostate-specific Antigen (PSA) Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…- CEACAM8(抗原遺伝子)市場：世界及び中国市場分析・予測（～2024年） CEACAM8(Antigen gene) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global CEACAM8(Antigen gene) industry with a focus on the Chinese market. The report provides key statistics on the market status of the CEACAM8(Antigen gene) manu…
- 白血球表面抗原CD47市場：世界及び中国市場分析・予測（～2024年） Leukocyte Surface Antigen CD47 Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Leukocyte Surface Antigen CD47 industry with a focus on the Chinese market. The report provides key statistics on the market status of the Leukocyt…
- 神経内分泌腫瘍治療の世界市場 2019年版：種類別（エベロリムス、スニチニブ、Lu-Dotatate、ランレオタイド、オクトレオチド）、用途別（病院、診療所、その他） Scope of the Report: The global Neuroendocrine Tumor Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in C…
- 手術用腫瘍アブレーションの世界市場 2019年版：種類別（高周波焼、マイクロ波焼、凍結焼、その他）、用途別（肝臓がん、乳がん、肺癌、前立腺がん、その他） Scope of the Report: The global Surgical Tumor Ablation market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…